Mulligan Brendan 4
4 · Figma, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Figma, Inc.FIG
Mulligan Brendan
General Counsel and Secretary
Transactions
- Sale
Class A Common Stock
2025-11-12$45.00/sh−10,000$450,000→ 903,181 total - Exercise/Conversion
Class A Common Stock
2025-11-10$23.19/sh+56,635$1,313,536→ 994,115 total - Sale
Class A Common Stock
2025-11-10$43.73/sh−36,623$1,601,374→ 921,943 total - Sale
Class A Common Stock
2025-11-10$44.51/sh−8,762$390,032→ 913,181 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-10−56,635→ 0 totalExercise: $23.19→ Class A Common Stock (56,635 underlying) - Sale
Class A Common Stock
2025-11-10$42.94/sh−35,549$1,526,534→ 958,566 total
Footnotes (6)
- [F1]The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2025.
- [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $42.32 and the highest price at which shares were sold was $43.31. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- [F3]Represents the weighted average sale price. The lowest price at which shares were sold was $43.32 and the highest price at which shares were sold was $44.29. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- [F4]Represents the weighted average sale price. The lowest price at which shares were sold was $44.32 and the highest price at which shares were sold was $44.76. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- [F5]The option is fully vested.
- [F6]The award will expire upon the earlier of (a) August 21, 2029 and (b) the date that is one year following the Issuer's IPO.